Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Afrigen Biologics and Vaccines.

    Client Virtual Booth

    AFRIGEN BIOLOGICS AND VACCINES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Afrigen Biologics and Vaccines
    SouthAfrica Flag
    Country
    Country
    South Africa
    Address
    Address
    Unit 5 Kestrel Park Longclaw Drive Montague Gardens Cape Town, 7441
    Telephone
    Telephone
    +2721 207 0101
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.afrigen.co.za/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/afrigen-biologics-pty-ltd?originalSubdomain=za
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea

    Details:

    The collaboration aims at developing a novel, prophylactic, mRNA vaccine, EVX-B2, based on Evaxion’s EDEN™ platform, a proprietary AI platform capable of rapidly identifying those antigens that will trigger a highly protective immune response, to discover gonorrhea targets.


    Lead Product(s): EVX-B2

    Therapeutic Area: Infections and Infectious Diseases Product Name: EVX-B2

    Highest Development Status: PreclinicalProduct Type: Vaccine

    Recipient: Evaxion Biotech

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration September 20, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Curapath Announces Collaboration with Afrigen Biologics to Advance Development of African-owned mRNA SARS-CoV-2 Vaccine

    Details:

    Under the collaboration, Curapath will be responsible for development of a scaled-up manufacturing process of the nanoparticle formulation for the m-RNA based vaccine and will assist in developing the fill/finish process.


    Lead Product(s): mRNA based SARS-CoV-2 Vaccine

    Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

    Highest Development Status: PreclinicalProduct Type: Vaccine

    Partner/Sponsor/Collaborator: Curapath

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration November 14, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    fermion-oy-2024-05-13

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search